Literature DB >> 26962229

KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.

Jeanette E Boudreau1, Tiernan J Mulrooney1, Jean-Benoît Le Luduec1, Edward Barker2, Katharine C Hsu3.   

Abstract

NK cells recognize self-HLA via killer Ig-like receptors (KIR). Homeostatic HLA expression signals for inhibition via KIR, and downregulation of HLA, a common consequence of viral infection, allows NK activation. Like HLA, KIR are highly polymorphic, and allele combinations of the most diverse receptor-ligand pair, KIR3DL1 and HLA-B, correspond to hierarchical HIV control. We used primary cells from healthy human donors to demonstrate how subtype combinations of KIR3DL1 and HLA-B calibrate NK education and their consequent capacity to eliminate HIV-infected cells. High-density KIR3DL1 and Bw4-80I partnerships endow NK cells with the greatest reactivity against HLA-negative targets; NK cells exhibiting the remaining KIR3DL1/HLA-Bw4 combinations demonstrate intermediate responsiveness; and Bw4-negative KIR3DL1(+) NK cells are poorly responsive. Cytotoxicity against HIV-infected autologous CD4(+) T cells strikingly correlated with reactivity to HLA-negative targets. These findings suggest that the programming of NK effector function results from defined features of receptor and ligand subtypes. KIR3DL1 and HLA-B subtypes exhibit an array of binding strengths. Like KIR3DL1, subtypes of HLA-Bw4 are expressed at distinct, predictable membrane densities. Combinatorial permutations of common receptor and ligand subtypes reveal binding strength, receptor density, and ligand density to be functionally important. These findings have immediate implications for prognosis in patients with HIV infection. Furthermore, they demonstrate how features of KIR and HLA modified by allelic variation calibrate NK cell reactive potential.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26962229      PMCID: PMC4868784          DOI: 10.4049/jimmunol.1502469

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

3.  Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Authors:  Sungjin Kim; Jennifer Poursine-Laurent; Steven M Truscott; Lonnie Lybarger; Yun-Jeong Song; Liping Yang; Anthony R French; John B Sunwoo; Suzanne Lemieux; Ted H Hansen; Wayne M Yokoyama
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

4.  Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

Authors:  Achim K Moesta; Paul J Norman; Makoto Yawata; Nobuyo Yawata; Michael Gleimer; Peter Parham
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

5.  KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population.

Authors:  S D Tao; Y M He; Y L Ying; J He; F M Zhu; H J Lv
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

6.  KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.

Authors:  William Henry Carr; Marcelo Jorge Pando; Peter Parham
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

7.  Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

Authors:  Katharine C Hsu; Carolyn A Keever-Taylor; Andrew Wilton; Clara Pinto; Glenn Heller; Knarik Arkun; Richard J O'Reilly; Mary M Horowitz; Bo Dupont
Journal:  Blood       Date:  2005-02-24       Impact factor: 22.113

Review 8.  Immunogenetics of killer cell immunoglobulin-like receptors.

Authors:  Peter Parham
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

9.  High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.

Authors:  R K Akkina; R M Walton; M L Chen; Q X Li; V Planelles; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  HLA alleles determine differences in human natural killer cell responsiveness and potency.

Authors:  Sungjin Kim; John B Sunwoo; Liping Yang; Taewoong Choi; Yun-Jeong Song; Anthony R French; Anna Vlahiotis; Jay F Piccirillo; Marina Cella; Marco Colonna; Thalachallour Mohanakumar; Katharine C Hsu; Bo Dupont; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more
  60 in total

1.  Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes.

Authors:  Veron Ramsuran; Pedro G Hernández-Sanchez; Colm O'hUigin; Gaurav Sharma; Niamh Spence; Danillo G Augusto; Xiaojiang Gao; Christian A García-Sepúlveda; Gurvinder Kaur; Narinder K Mehra; Mary Carrington
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 2.  Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection.

Authors:  Katharina Fleischhauer; Katharine C Hsu; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-05-24       Impact factor: 5.483

3.  HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells.

Authors:  Christian Körner; Camille R Simoneau; Philipp Schommers; Mitchell Granoff; Maja Ziegler; Angelique Hölzemer; Sebastian Lunemann; Janet Chukwukelu; Björn Corleis; Vivek Naranbhai; Douglas S Kwon; Eileen P Scully; Stephanie Jost; Frank Kirchhoff; Mary Carrington; Marcus Altfeld
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

4.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

5.  CD8αα homodimers function as a coreceptor for KIR3DL1.

Authors:  Jie Geng; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-16       Impact factor: 11.205

Review 6.  Strategies for the measurements of expression levels and half-lives of HLA class I allotypes.

Authors:  Malini Raghavan; Brogan Yarzabek; Anita J Zaitouna; Sujatha Krishnakumar; Daniel S Ramon
Journal:  Hum Immunol       Date:  2019-02-05       Impact factor: 2.850

Review 7.  How important is NK alloreactivity and KIR in allogeneic transplantation?

Authors:  Brian C Shaffer; Katharine C Hsu
Journal:  Best Pract Res Clin Haematol       Date:  2016-10-20       Impact factor: 3.020

8.  Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.

Authors:  Kirsten M Anderson; Danillo G Augusto; Ravi Dandekar; Hengameh Shams; Chao Zhao; Tasneem Yusufali; Gonzalo Montero-Martín; Wesley M Marin; Neda Nemat-Gorgani; Lisa E Creary; Stacy Caillier; Mohammad R K Mofrad; Peter Parham; Marcelo Fernández-Viña; Jorge R Oksenberg; Paul J Norman; Jill A Hollenbach
Journal:  J Immunol       Date:  2020-07-24       Impact factor: 5.422

Review 9.  Memory responses of natural killer cells.

Authors:  Clair D Geary; Joseph C Sun
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

Review 10.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.